This paper is in the following e-collection/theme issue:

Neurology and Neurosciences (185)

Published on in Vol 2, No 1 (2013): Jan-Jun

Severe Loss of Appetite in Amyotrophic Lateral Sclerosis Patients: Online Self-Assessment Study

Severe Loss of Appetite in Amyotrophic Lateral Sclerosis Patients: Online Self-Assessment Study

Severe Loss of Appetite in Amyotrophic Lateral Sclerosis Patients: Online Self-Assessment Study

Authors of this article:

Teresa Holm1 ;   André Maier1 Author Orcid Image ;   Paul Wicks2 Author Orcid Image ;   Dirk Lang3 ;   Peter Linke1 ;   Christoph Münch1 ;   Laura Steinfurth1 ;   Robert Meyer1 ;   Thomas Meyer1
Article Authors Cited by (37) Tweetations (1) Metrics

Journals

  1. Lisiecka D, Kelly H, Jackson J. How do people with Motor Neurone Disease experience dysphagia? A qualitative investigation of personal experiences. Disability and Rehabilitation 2021;43(4):479 View
  2. Ahmed R, Ke Y, Vucic S, Ittner L, Seeley W, Hodges J, Piguet O, Halliday G, Kiernan M. Physiological changes in neurodegeneration — mechanistic insights and clinical utility. Nature Reviews Neurology 2018;14(5):259 View
  3. Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, Kawata A, Isozaki E. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. Journal of Neurology 2019;266(6):1412 View
  4. Ngo S, van Eijk R, Chachay V, van den Berg L, McCombe P, Henderson R, Steyn F. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019;20(7-8):497 View
  5. Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, Chiò A. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. Journal of Neurology, Neurosurgery & Psychiatry 2019;90(6):666 View
  6. Zarotti N, Coates E, McGeachan A, Williams I, Beever D, Hackney G, Norman P, Stavroulakis T, White D, White S, Halliday V, McDermott C. Health care professionals’ views on psychological factors affecting nutritional behaviour in people with motor neuron disease: A thematic analysis. British Journal of Health Psychology 2019;24(4):953 View
  7. Tracey T, Kirk S, Steyn F, Ngo S. The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Seminars in Cell & Developmental Biology 2021;112:69 View
  8. Tokudome Y, Okumura K, Kumagai Y, Hirano H, Kim H, Morishita S, Watanabe Y. Development of the Japanese version of the Council on Nutrition Appetite Questionnaire and its simplified versions, and evaluation of their reliability, validity, and reproducibility. Journal of Epidemiology 2017;27(11):524 View
  9. Colldén G, Tschöp M, Müller T. Therapeutic Potential of Targeting the Ghrelin Pathway. International Journal of Molecular Sciences 2017;18(4):798 View
  10. Janse van Mantgem M, van Eijk R, van der Burgh H, Tan H, Westeneng H, van Es M, Veldink J, van den Berg L. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 2020;91(8):867 View
  11. Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Ishikawa-Takata K, Isozaki E. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Scientific Reports 2019;9(1) View
  12. Czell D, Baldinger R, Schneider U, Neuwirth C, Weber M. The role of the SenseWear device and ghrelin for metabolism in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016;17(3-4):295 View
  13. Mezoian T, Belt E, Garry J, Hubbard J, Breen C, Miller L, Levine‐Weinberg M, Nalipinski P, Sullivan S, Chan J, Wills A. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle & Nerve 2020;61(2):230 View
  14. Scagnelli C, Howard D, Bromberg M, Kasarskis E, Matthews D, Mitsumoto H, Simmons Z, Tandan R. Hydration measured by doubly labeled water in ALS and its effects on survival. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2018;19(3-4):220 View
  15. Shimizu T, Ishikawa-Takata K, Sakata A, Nagaoka U, Ichihara N, Ishida C, Nakayama Y, Komori T, Nishizawa M. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labelled water method study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2017;18(1-2):37 View
  16. Ngo S, Steyn F, McCombe P. Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2014;340(1-2):5 View
  17. Dorst J, Cypionka J, Ludolph A. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013;14(7-8):533 View
  18. Chalmers J, Tung Y, Liu C, O'Kane C, O'Rahilly S, Yeo G. A multicomponent screen for feeding behaviour and nutritional status in Drosophila to interrogate mammalian appetite-related genes. Molecular Metabolism 2021;43:101127 View
  19. Ngo S, Wang H, Henderson R, Bowers C, Steyn F. Ghrelin as a treatment for amyotrophic lateral sclerosis. Journal of Neuroendocrinology 2021;33(7) View
  20. Tefera T, Steyn F, Ngo S, Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?. Cell & Bioscience 2021;11(1) View
  21. Wang Y, Ye S, Chen L, Tang L, Fan D. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Scientific Reports 2021;11(1) View
  22. Waheed W, Khan F, Naud S, Kasarskis E, Matthews D, Tandan R. Urine specific gravity to identify and predict hydration need in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2022;23(5-6):407 View
  23. Guillot S, Bolborea M, Dupuis L. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis. Current Opinion in Neurology 2021;34(5):773 View
  24. Sarmet M, Kabani A, Maragakis N, Mehta A. Appetite and quality of life in amyotrophic lateral sclerosis: A scoping review. Muscle & Nerve 2022;66(6):653 View
  25. Nelson A, Trotti D. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 2022;19(4):1102 View
  26. Nagaoka U, Shimizu T, Uchihara T, Komori T, Hosoda H, Takahashi K. Decreased plasma ghrelin in male ALS patients is associated with poor prognosis. Neuroscience Research 2022;177:111 View
  27. Chiò A, Canosa A, Calvo A, Moglia C, Cicolin A, Mora G. Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 2021;21(12):1419 View
  28. Ferrer-Donato A, Contreras A, Frago L, Chowen J, Fernandez-Martos C. Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS). International Journal of Molecular Sciences 2021;22(19):10305 View
  29. Maier A, Münch C, Meyer T. Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose. Klinische Neurophysiologie 2023;54(01):28 View
  30. Rogers C, Ramirez M, Landon C, DeBlasi J, Koutnik A, Ari C, D’Agostino D. A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS. Nutrients 2023;15(8):1821 View
  31. Tzeplaeff L, Wilfling S, Requardt M, Herdick M. Current State and Future Directions in the Therapy of ALS. Cells 2023;12(11):1523 View
  32. Maksimovic K, Youssef M, You J, Sung H, Park J. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models. Biomolecules 2023;13(5):863 View
  33. Abbasi H, Jourabchi-ghadim N, Asgarzade A, Mirshekari M, Ebrahimi-Mameghani M. Unveiling the veil of adipokines: A meta-analysis and systematic review in amyotrophic lateral sclerosis. Neuroscience 2024;563:1 View

Books/Policy Documents

  1. Stavroulakis T, McDermott C. Nutrition in Neurologic Disorders. View
  2. Ngo S, Steyn F, McCombe P, Borges K. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. View
  3. Ahmed R, Steyn F, Dupuis L. The Human Hypothalamus - Middle and Posterior Region. View
  4. Holdom C, Steyn F, Henderson R, McCombe P, Rogers M, Ngo S. Neurodegenerative Diseases Biomarkers. View